title: Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015;16:76-86.
authors: Department of Urology, Saarland University Medical Centre, Homburg/Saar, Germany. Electronic address: carsten.ohlmann@uks.eu.
authors: Carsten-Henning
authors: CH
authors: Ohlmann
authors: Department of Urology, Saarland University Medical Centre, Homburg/Saar, Germany.
authors: Michael
authors: M
authors: Stöckle
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000601:surgery*; D015653:Cystectomy; D005260:Female; D006801:Humans; D008297:Male; D061665:Time-to-Treatment; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D019459:Urothelium / Q000187:drug effects* / Q000601:surgery*